Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Ramucirumab × Clear all

Sponsor

Conditions

Stomach Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Carcinoma, Hepatocellular 6 Adenocarcinoma 6 Neoplasms 5 Colorectal Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms 4 Urethral Neoplasms 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Liver Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Ureteral Neoplasms 2 Solid Tumors 2 Sarcoma 2 Non-small Cell Lung Cancer Metastatic 2 Malignant Solid Tumor 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Biliary Tract Neoplasms 2 Thymoma 1 Sarcoma, Synovial 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Metastatic Gastric Adenocarcinoma 1

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡